MedPath
NMPA Approval

Febuxostat Tablets

国药准字H20130058

March 3, 2023

Drug Information

非布司他片

优立通

片剂

40mg

化学药品

March 3, 2023

Company Information

Applicant Company

江苏省徐州市金山桥开发区综合区洞山南侧

Manufacturing Company

江苏省徐州市金山桥开发区综合区洞山南侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

非布司他片 - NMPA 批准文号 | MedPath